These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2799284)

  • 1. Gastric cancer detected by mass survey. Comparison between mass survey and outpatient detection.
    Kampschöer GH; Fujii A; Masuda Y
    Scand J Gastroenterol; 1989 Sep; 24(7):813-7. PubMed ID: 2799284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of gastric cancer detected by mass survey. Comparison with those of outpatients].
    Fujii A; Masuda Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):937-43. PubMed ID: 3389837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of gastric carcinoma detected by gastric mass survey in Japan.
    Kaneko E; Nakamura T; Umeda N; Fujino M; Niwa H
    Gut; 1977 Aug; 18(8):626-30. PubMed ID: 892608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass screening for gastric cancer by X-ray examination.
    Hisamichi S; Sugawara N
    Jpn J Clin Oncol; 1984 Jun; 14(2):211-23. PubMed ID: 6737710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [End results of gastric cancer detected by mass survey: analysis using the relative survival rate curve].
    Arisue T; Tamura K; Tebayashi A
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):929-36. PubMed ID: 3389836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer.
    Maehara Y; Kakeji Y; Oda S; Takahashi I; Akazawa K; Sugimachi K
    Br J Cancer; 2000 Oct; 83(8):986-91. PubMed ID: 10993643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of a gastric mass screening survey.
    Shiratori Y; Nakagawa S; Kikuchi A; Ishii M; Ueno M; Miyashita T; Sakurai T; Negami J; Suzuki T; Sato I
    Am J Gastroenterol; 1985 Nov; 80(11):831-4. PubMed ID: 4050756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gastric mass survey.
    Okui K; Tejima H
    Acta Chir Scand; 1980; 146(3):185-7. PubMed ID: 7468039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years.
    Miyahara R; Niwa Y; Matsuura T; Maeda O; Ando T; Ohmiya N; Itoh A; Hirooka Y; Goto H
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1435-42. PubMed ID: 17573829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of gastric cancer detected by mass screening.
    Hanazaki K; Sodeyama H; Wakabayashi M; Miyazawa M; Yokoyama S; Sode Y; Kawamura N; Miyazaki T; Ohtsuka M
    Hepatogastroenterology; 1997; 44(16):1126-32. PubMed ID: 9261611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing incidence and excellent survival of patients with early gastric cancer: experience in a United States medical center.
    Green PH; O'Toole KM; Slonim D; Wang T; Weg A
    Am J Med; 1988 Nov; 85(5):658-61. PubMed ID: 3189369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of gastric mass screening in Japan.
    Hisamichi S; Sugawara N; Fukao A
    Cancer Detect Prev; 1988; 11(3-6):323-9. PubMed ID: 3390854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of gastric cancer. 'Real' 5-year survival rates and mortality rates in a country with high incidence.
    Cenitagoya GF; Bergh CK; Klinger-Roitman J
    Dig Surg; 1998; 15(4):317-22. PubMed ID: 9845606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer mass survey in Chile.
    Llorens P
    Semin Surg Oncol; 1991; 7(6):339-43. PubMed ID: 1759081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is gastric carcinoma different between Japan and the United States?
    Noguchi Y; Yoshikawa T; Tsuburaya A; Motohashi H; Karpeh MS; Brennan MF
    Cancer; 2000 Dec; 89(11):2237-46. PubMed ID: 11147594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of mass survey for gastric cancer from the standpoint of surgery.
    Kaibara N; Kawaguchi H; Nishidoi H; Kimura O; Okamoto T; Koga S; Fukumoto S
    Am J Surg; 1981 Nov; 142(5):543-5. PubMed ID: 7304807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of mass screening program for stomach cancer.
    Hisamichi S; Nozaki K; Kitagawa M; Mochizuki F; Gomi T
    Tohoku J Exp Med; 1976; 118 Suppl():69-77. PubMed ID: 964032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC).
    Folli S; Morgagni P; Roviello F; De Manzoni G; Marrelli D; Saragoni L; Di Leo A; Gaudio M; Nanni O; Carli A; Cordiano C; Dell'Amore D; Vio A;
    Jpn J Clin Oncol; 2001 Oct; 31(10):495-9. PubMed ID: 11696619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.